Nuveen Asset Management’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-18,630
| Closed | -$2.04M | – | 3391 |
|
2022
Q1 | $2.04M | Buy |
18,630
+5,057
| +37% | +$554K | ﹤0.01% | 2493 |
|
2021
Q4 | $2.3M | Buy |
13,573
+5,388
| +66% | +$913K | ﹤0.01% | 2504 |
|
2021
Q3 | $2.24M | Buy |
8,185
+33
| +0.4% | +$9.01K | ﹤0.01% | 2617 |
|
2021
Q2 | $3.23M | Buy |
8,152
+2,326
| +40% | +$921K | ﹤0.01% | 2476 |
|
2021
Q1 | $3.15M | Sell |
5,826
-134
| -2% | -$72.4K | ﹤0.01% | 2400 |
|
2020
Q4 | $2.25M | Sell |
5,960
-675
| -10% | -$255K | ﹤0.01% | 2446 |
|
2020
Q3 | $2.51M | Sell |
6,635
-488
| -7% | -$184K | ﹤0.01% | 2275 |
|
2020
Q2 | $3.51M | Buy |
7,123
+1,717
| +32% | +$845K | ﹤0.01% | 2082 |
|
2020
Q1 | $1.99M | Buy |
5,406
+554
| +11% | +$204K | ﹤0.01% | 2191 |
|
2019
Q4 | $3.44M | Sell |
4,852
-52
| -1% | -$36.8K | ﹤0.01% | 2184 |
|
2019
Q3 | $3.15M | Buy |
4,904
+272
| +6% | +$175K | ﹤0.01% | 2192 |
|
2019
Q2 | $4.05M | Buy |
+4,632
| New | +$4.05M | ﹤0.01% | 2098 |
|